See more : Laxmi Goldorna House Ltd (LGHL.NS) Income Statement Analysis – Financial Results
Complete financial analysis of National Peroxide Limited (NATPEROX.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Peroxide Limited, a leading company in the industry within the sector.
- Kingfisher plc (KGF.L) Income Statement Analysis – Financial Results
- Loyal Solutions A/S (LOYAL.ST) Income Statement Analysis – Financial Results
- Phio Pharmaceuticals Corp. (PHIO) Income Statement Analysis – Financial Results
- Ocean Outdoor Limited (OOUT.L) Income Statement Analysis – Financial Results
- Unitil Corporation (UTL) Income Statement Analysis – Financial Results
National Peroxide Limited (NATPEROX.BO)
Industry: Chemicals
Sector: Basic Materials
About National Peroxide Limited
Naperol Investments Limited manufactures and sells peroxygens in India and internationally. The company offers hydrogen peroxide that is used in various industries, including chemical synthesis, textile bleaching, paper pulp bleaching, sugar bleaching, non-edible oil bleaching, water and effluent treatment, metallurgy, and other applications. It also provides compressed hydrogen gas and peracetic acid. The company was formerly known as National Peroxide Limited and changed its name to Naperol Investments Limited in December 2023. Naperol Investments Limited was incorporated in 1954 and is headquartered in Mumbai, India.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 8.00M | 2.81M | 2.15B | 1.91B | 4.02B |
| Cost of Revenue | 7.98M | 2.01B | 1.63B | 1.57B | 1.60B |
| Gross Profit | 21.00K | -2.01B | 520.49M | 341.81M | 2.41B |
| Gross Profit Ratio | 0.26% | -71,265.14% | 24.21% | 17.88% | 60.10% |
| Research & Development | 0.00 | 1.29M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.23M | 78.26M | 87.25M | 61.93M | 0.00 |
| Selling & Marketing | 6.90M | 16.06M | 40.86M | 35.92M | 0.00 |
| SG&A | 9.13M | 13.23M | 212.72M | 162.14M | 222.97M |
| Other Expenses | 10.06M | 1.29M | -3.28M | -5.90M | 0.00 |
| Operating Expenses | 9.13M | 13.23M | 216.00M | 168.04M | 222.97M |
| Cost & Expenses | 17.11M | 13.23M | 1.85B | 1.74B | 1.83B |
| Interest Income | 14.00K | 0.00 | 111.60M | 165.36M | 162.83M |
| Interest Expense | 62.21M | 88.34M | 126.56M | 136.06M | 9.32M |
| Depreciation & Amortization | 228.49K | -174.37M | -175.00M | -112.28M | -92.32M |
| EBITDA | -9.11M | 163.95M | 479.49M | 286.06M | 2.28B |
| EBITDA Ratio | -113.88% | 5,826.12% | 22.30% | 14.96% | 56.85% |
| Operating Income | -9.11M | -10.42M | 304.49M | 173.78M | 2.19B |
| Operating Income Ratio | -113.88% | -370.22% | 14.16% | 9.09% | 54.55% |
| Total Other Income/Expenses | 3.77B | 25.63M | -181.58M | 121.81M | 169.30M |
| Income Before Tax | 3.76B | 15.21M | 122.92M | 295.59M | 2.36B |
| Income Before Tax Ratio | 47,017.48% | 540.65% | 5.72% | 15.46% | 58.76% |
| Income Tax Expense | 8.42M | 8.74M | -88.85M | 116.43M | 822.22M |
| Net Income | 3.75B | 50.86M | 211.77M | 179.16M | 1.54B |
| Net Income Ratio | 46,912.20% | 1,807.43% | 9.85% | 9.37% | 38.29% |
| EPS | 652.95 | 8.85 | 36.85 | 31.17 | 267.61 |
| EPS Diluted | 652.95 | 8.85 | 36.85 | 31.17 | 267.61 |
| Weighted Avg Shares Out | 5.75M | 5.75M | 5.75M | 5.75M | 5.75M |
| Weighted Avg Shares Out (Dil) | 5.75M | 5.75M | 5.75M | 5.75M | 5.75M |
Source: https://incomestatements.info
Category: Stock Reports